Anzeige
Mehr »
Donnerstag, 05.03.2026 - Börsentäglich über 12.000 News
"Unbegrenzte Munition?" - Ohne diesen kritischen Rohstoff bleibt es wohl nur ein Versprechen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2QML9 | ISIN: KYG6082P1054 | Ticker-Symbol: 72X
Lang & Schwarz
05.03.26 | 11:58
0,150 Euro
-100,00 % -0,150
Branche
Gesundheitswesen
Aktienmarkt
ASIEN
1-Jahres-Chart
MICROPORT CARDIOFLOW MEDTECH CORPORATION Chart 1 Jahr
5-Tage-Chart
MICROPORT CARDIOFLOW MEDTECH CORPORATION 5-Tage-Chart
RealtimeGeldBriefZeit
0,1000,20011:58
0,0000,00007:31

Aktuelle News zur MICROPORT CARDIOFLOW MEDTECH Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MICROPORT CARDIOFLOW MEDTECH Aktie jetzt für 0€ handeln
24.02.MP CARDIOFLOW-B (02160): NEXT DAY DISCLOSURE RETURN1
24.02.MP CARDIOFLOW-B (02160): SHARE CONSOLIDATION BECOMING EFFECTIVE2
24.02.XFRA 72X: AUSSETZUNG/SUSPENSION91DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILMICROPORT CARDIO.MEDTECH....
► Artikel lesen
23.02.XFRA CAPITAL ADJUSTMENT INFORMATION - 23.02.2026290Das Instrument K1SN CA4987222060 KLONDIKE SILVER CORP. EQUITY wird cum Kapitalmassnahme gehandelt am 23.02.2026 und ex Kapitalmassnahme am 24.02.2026 The instrument K1SN CA4987222060 KLONDIKE SILVER...
► Artikel lesen
13.02.MP CARDIOFLOW-B (02160): VOLUNTARY ANNOUNCEMENT - THE IMPLANTABLE CARDIOVERTER DEFIBRILLATOR ENTERED THE SPECIAL REVIEW PROCEDURE FOR INNOVATIVE MEDICAL ...-
11.02.MP CARDIOFLOW-B (02160): (I) POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON FEBRUARY 11, 2026; (II) SHARE CONSOLIDATION BECOMING EFFECTIVE ...-
30.01.MP CARDIOFLOW-B (02160): REVISED EXPECTED TIMETABLE IN RELATION TO THE PROPOSED SHARE CONSOLIDATION-
26.01.MP CARDIOFLOW-B (02160): FORM OF PROXY FOR USE AT THE EXTRAORDINARY GENERAL MEETING TO BE HELD ON WEDNESDAY, FEBRUARY 11, 20261
26.01.MP CARDIOFLOW-B (02160): NOTICE OF EXTRAORDINARY GENERAL MEETING-
26.01.MP CARDIOFLOW-B (02160): PROPOSED SHARE CONSOLIDATION AND NOTICE OF EXTRAORDINARY GENERAL MEETING1
22.01.MP CARDIOFLOW-B (02160): CLOSURE OF REGISTER OF MEMBERS-
30.12.25MP CARDIOFLOW-B (02160): VOLUNTARY ANNOUNCEMENT - OVERSEAS PROGRESS OF TAVI BUSINESS1
30.12.25MP CARDIOFLOW-B (02160): VOLUNTARY ANNOUNCEMENT - FORMAL RELEASE OF ONE-YEAR FOLLOW-UP RESULTS FROM THE EARLY FEASIBILITY STUDY OF ALTAVALVE1
15.12.25CARDIOFLOW-B (02160): LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS3
15.12.25CARDIOFLOW-B (02160): (1) CHANGE IN COMPOSITION OF AUDIT COMMITTEE, REMUNERATION COMMITTEE AND NOMINATION COMMITTEE; (2) ESTABLISHMENT OF STRATEGY COMMITTEE; ...1
15.12.25CARDIOFLOW-B (02160): (1) CHANGE OF DIRECTORS AND APPOINTMENT OF DEPUTY PRESIDENT; AND (2) CHANGE OF STOCK SHORT NAME1
15.12.25CARDIOFLOW-B (02160): POLL RESULTS OF EXTRAORDINARY GENERAL MEETING HELD ON DECEMBER 15, 20252
25.11.25CARDIOFLOW-B (02160): SUPPLEMENTAL ANNOUNCEMENT1
24.11.25CARDIOFLOW-B (02160): FORM OF PROXY FOR USE AT THE EXTRAORDINARY GENERAL MEETING TO BE HELD ON MONDAY, DECEMBER 15, 20252
24.11.25CARDIOFLOW-B (02160): NOTICE OF EXTRAORDINARY GENERAL MEETING1
Weiter >>
23 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1